# A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer

> **NCT05365230** · PHASE4 · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 261 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** On-demand personalized follow-up care
- **OTHER:** Guideline-based follow-up care (standard of care)

## Key facts

- **NCT ID:** NCT05365230
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-19
- **Primary completion:** 2025-04-14
- **Final completion:** 2025-08-15
- **Target enrollment:** 261 (ACTUAL)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05365230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05365230, "A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05365230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*